"Developing novel treatments for Dormant Cancers - targeting resistance, metastasis, and relapse."

January 4, 2021           The Journal of Clinical Investigation

 

"DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3"

April 28, 2020              AACR Annual Meeting

 

Abstract Number: 5161

Validation of drug candidates targeting dormant cancers in live cells as a key for successful translation into the clinics

March, 2020                 Patent granted

May 26, 2019               ASCO Annual Meeting

 

Abstract Number: 14670

Implication of DYRK1B kinase in dormant glioblastoma cancers and utilization of DYRK1B inhibitors as a novel therapeutic strategy for glioblastoma.

April 2, 2019                AACR Annual Meeting

 

Abstract Number: 3038

Implications of DYRK1B kinase in ovarian cancers and utilization of DYRK1B inhibitors as a novel therapeutic strategy for ovarian cancers

February, 2019            Journal of Molecular Modeling

January 11, 2016          8th Annual BIOTECH Showcase

Oral presentation

Date and Time:  January 13th 2016 8AM

Location: The Parc 55 San Francisco Track A